| Identification | Back Directory | [Name]
DIHYDROCODEINE TRIFLUOROACETATE | [CAS]
125-28-0 | [Synonyms]
Didrate
Drocode
Nadeine
Parzone
Drocade
Novcodin
Dihydrin
Cohydrin
Dehacodin
Novicodin
Rapacodin
Rapocodin
Paracodin
Paracodine
Novicondin
Hydrocodin
DH-codeine
Codhydrine
Novicodine
NSC 231319
α-Hydrocodol
Hydrocodeine
6α-Hydrocodol
Dihydrokodein
Dihydroneopine
alpha-Hydrocodol
Codeine, dihydro-
6alpha-Hydrocodol
7,8-dihydro-codein
7,8-Dihydrocodeine
6-alpha-hydrocodol
Dihydrocodeine HCl
8,14-Dihydroneopine
Dihydrocodeine (CRM)
RBOXVHNMENFORY-DNJOTXNNSA-N
Codeine, 7,8-dihydro- (6CI)
DIHYDROCODEINE TRIFLUOROACETATE
Dihydrocodeine hydrochloride solution
Dihydrocodeine (base and/or unspecified salts)
6-Hydroxy-3-methoxy-N-methyl-4,5-epoxymorphinan
4,5alpha-Epoxy-3-methoxy-17-methylmorphinan-6alpha-ol
Morphinan-6α-ol, 4,5α-epoxy-3-methoxy-17-methyl- (8CI)
4,5-alpha-epoxy-3-methoxy-17-methyl-morphinan-6-alpha-o
Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5α,6α)-
Morphinan-6alpha-ol, 4,5alpha-epoxy-3-methoxy-17-methyl-
Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-
3-Methoxy-12-methyl-5,6,7,7α,8,9-hexahydro-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5-ol | [EINECS(EC#)]
204-732-3 | [Molecular Formula]
C20H24F3NO4 | [MDL Number]
MFCD02253008 | [MOL File]
125-28-0.mol | [Molecular Weight]
399.4 |
| Safety Data | Back Directory | [Hazard Codes ]
F,T | [Risk Statements ]
11-23/24/25-39/23/24/25 | [Safety Statements ]
7-16-36/37-45 | [RIDADR ]
UN1230 - class 3 - PG 2 - Methanol, solution | [Safety Profile]
Poison by ingestion,
intravenous, and subcutaneous routes.
Human systemic effects by ingestion and
subcutaneous routes: somnolence, miosis
(pupillary constriction), and respiratory
depression. An analgesic. Can cause drug
dependency with repeated doses. When
heated to decomposition it emits toxic
fumes of NOx. See also CODEINE. |
| Hazard Information | Back Directory | [Originator]
Bicodein,Uquifa | [Definition]
ChEBI: Dihydrocodeine is a morphinane alkaloid. | [Manufacturing Process]
The codein was reduced by hydrogen in the presence catalyst Pt (or Pd, or Ni)
and 7,8-dihydrocodein was obtained.
To the 7,8-dihydrocodein tartaric acid was added and mixed, in the result 7,8-
dihydrocodein bitartrate was obtained. | [Therapeutic Function]
Antitussive, Narcotic analgesic
|
|